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ABSTRACT Mycobacterium tuberculosis induces metabolic reprogramming in macro-
phages like the Warburg effect. This enhances antimicrobial performance at the
expense of increased inflammation, which may promote a pathogen-permissive host
environment. Since the NAD1-dependent protein deacetylase Sirtuin 3 (SIRT3) is an
important regulator of mitochondrial metabolism and cellular redox homeostasis, we
hypothesized that SIRT3 modulation mediates M. tuberculosis-induced metabolic
reprogramming. Infection of immortalized and primary murine macrophages
resulted in reduced levels of SIRT3 mRNA and protein and perturbation of SIRT3-
regulated enzymes in the tricarboxylic acid cycle, electron transport chain, and gly-
colytic pathway. These changes were associated with increased reactive oxygen
species and reduced antioxidant scavenging, thereby triggering mitochondrial
stress and macrophage cell death. Relevance to tuberculosis disease in vivo was
indicated by greater bacterial burden and immune pathology in M. tuberculosis-
infected Sirt32/2 mice. CD11b1 lung leukocytes isolated from infected Sirt32/2 mice
showed decreased levels of enzymes involved in central mitochondrial metabolic
pathways, along with increased reactive oxygen species. Bacterial burden was also
greater in lungs of LysMcreSirt3L2/L2 mice, demonstrating the importance of macro-
phage-specific SIRT3 after infection. These results support the model of SIRT3 as a
major upstream regulatory factor, leading to metabolic reprogramming in macro-
phages by M. tuberculosis.
IMPORTANCE Tuberculosis, the disease caused by the bacterium M. tuberculosis,
remains one of the top 10 causes of death worldwide. Macrophages, the first cells to
encounter M. tuberculosis and critical for defense against infection, are hijacked by
M. tuberculosis as a protected growth niche. M. tuberculosis-infected macrophages
undergo metabolic reprogramming where key mitochondrial pathways are modu-
lated, but the mechanisms driving this metabolic shift is unknown. Our study dem-
onstrates that M. tuberculosis downregulates Sirtuin 3 (SIRT3), an important regulator
of mitochondrial metabolism, leading to SIRT3-dependent transcriptional downreg-
ulation of mitochondrial metabolic proteins, which is followed by oxidative stress
and macrophage necrosis. This study identifies SIRT3 modulation as a key event
in M. tuberculosis-induced metabolic reprograming in macrophages that defend
against tuberculosis.
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Macrophages are the first immune cells to encounter inhaled Mycobacterium tuber-culosis. The bacillus blocks phagosome maturation, reprograms metabolism, and
induces cell death in infected macrophages (1). Infection by M. tuberculosis skews mac-
rophage metabolism from oxidative phosphorylation (OXPHOS) toward aerobic glycol-
ysis, comparable to the Warburg effect. This altered metabolic state may represent a
host defense to fuel a rapid inflammatory response (2–6). However, Hackett et al. (7)
reported repression of glycolysis following persistent M. tuberculosis infection in mac-
rophages, which depended on upregulation of microRNA-21. Cumming et al. (8)
described decelerated flux through both glycolysis and OXPHOS in human macro-
phages following infection. Despite these contrasting studies, available evidence con-
sistently points toward mitochondrial metabolic reprogramming initiated by the bacil-
lus. Mitochondria are a major source for reactive oxygen species (ROS) in macrophages
and participate in M. tuberculosis-activated apoptotic and necrotic cell death (9, 10),
raising the question whether shared mechanisms underlie perturbation of macrophage
metabolism and cell fate.
Cellular metabolism is controlled by energy sensors that include sirtuins (SIRTs) (11,
12), a family of seven NAD1-dependent protein deacetylases with distinct subcellular
localizations and target proteins (13). SIRT3, the major mitochondrial sirtuin, regulates
central metabolism, energy balance, and cellular redox (14–18) and is a regulator of
metabolic reprogramming in cancer cells (19). Kim et al. recently reported that SIRT3
enhances anti-M. tuberculosis activity in macrophages by mediating autophagy, pre-
serving mitochondrial function, and limiting ROS accumulation (20). However, the role
SIRT3 plays in the metabolic reprogramming and ROS-mediated death of infected mac-
rophages remains unexplored.
Here, we show that M. tuberculosis infection of macrophages downregulated SIRT3
in a TLR2-dependent manner, resulting in perturbation of enzymes in the tricarboxylic
acid (TCA) cycle, electron transport chain (ETC), and glycolytic pathways. This led to
increased mitochondrial ROS (mtROS), and cell death. Using SIRT3-deficient primary
bone-marrow derived macrophages (BMDM) and CD11b1 lung leukocytes isolated
from M. tuberculosis-infected Sirt32/2 mice, we show that the changes in TCA, ETC, and
glycolytic enzymes were regulated in vitro and in vivo in a SIRT3-dependent manner.
Finally, SIRT3 was shown to be required for optimal host protection against M. tubercu-
losis infection in vivo. We propose that SIRT3 modulation by M. tuberculosis is a key
upstream event leading to metabolic reprogramming and macrophage dysfunction in
tuberculosis (TB).
RESULTS
Altered metabolic profile inM. tuberculosis-infected macrophages.We analyzed
the impact of M. tuberculosis Erdman infection on the expression of genes involved in
central metabolic pathways using J2-immortalized murine macrophages and wild-type
(WT) primary C57BL/6J mouse BMDM and resident peritoneal macrophages (RPM). The
expression of hexokinase 2 (Hk2), the platelet isoform of phosphofructokinase (Pfkp),
and glucose transporter 1 (Glut1), three rate-limiting enzymes in the glycolytic pathway
(21, 22), was increased 24 h postinfection (p.i.) in J2 macrophages (Fig. 1A and B). The
muscle and liver isoforms of phosphofructokinase (Pfkm and Pfkl, respectively) were
decreased or unchanged (Fig. 1A). Mouse RPM also showed a 2.4-fold increase in Hk2
at 24 h p.i. (see Fig. S1A in the supplemental material). Consistent with increased glyco-
lytic gene expression, and in agreement with prior evidence that M. tuberculosis
promotes glycolysis (3, 4, 23), secreted lactate levels were;50% higher in M. tuberculo-
sis-infected J2 macrophages (Fig. 1C). Expression levels of the pentose phosphate path-
way enzymes glucose-6 phosphate dehydrogenase (G6pd) and 6-phosphogluconate
dehydrogenase (Pgd) were also increased (Fig. 1D). These results showed that M. tuber-
culosis induced the glycolytic and pentose phosphate pathways in macrophages.
To further assess metabolic alterations after infection, the transcriptional profiles of
tricarboxylic acid (TCA) cycle and ETC components were analyzed. Expression of
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FIG 1 Altered metabolic profile in M. tuberculosis-infected macrophages. (A and B) Gene expression of hexokinase-2 (Hk2) and
phosphofructokinase, platelet (Pfkp), muscle (Pfkm), and liver (Pfkl) type (A) and glucose transporter 1 (Glut1) (B) in J2 macrophages at
24 h p.i. with M. tuberculosis (MOI of 10). The data are expressed relative to uninfected macrophages and show the means 6 the SD
of four independent experiments. (C) Secreted lactate levels from J2 macrophages with identical conditions as in panel A. Error bars
show the means 6 the SD of four independent experiments. (D and E) Gene expression of glucose-6-phosphate dehydrogenase
(G6pd) and 6-phosphogluconate dehydrogenase (Pgd) (D) and isocitrate dehydrogenase 2 (Idh2) (E) in J2 macrophages with identical
conditions and analysis as in panel A. (F, left) Representative immunoblot showing total IDH2 or b-Actin and acetylated IDH2 in J2
macrophage cell lysate following immunoprecipitation with acetyl-lysine with identical infection conditions as in panel A. (Right)
Densitometry of immunoblots showing total IDH2 normalized to b-actin and total to acetylated IDH2. The data are expressed relative
(Continued on next page)
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isocitrate dehydrogenase 2 (Idh2), a TCA cycle enzyme that catalyzes the decarboxyl-
ation of isocitrate to 2-oxoglutarate (15), was decreased by 40% in M. tuberculosis-
infected J2 macrophages (Fig. 1E), RPM, and BMDM (see Fig. S1A and B). Activity of
IDH2 is regulated through acetylation at lysine residues, where deacetylated IDH2 is
more active (15). To analyze IDH2 acetylation in M. tuberculosis-infected J2 macro-
phages, acetylated proteins were immunoprecipitated, followed by immunoblotting
with IDH2. While total IDH2 levels were decreased at 24 h p.i., the ratio of acetylated to
total IDH2 was increased compared to uninfected controls (Fig. 1F), suggesting that M.
tuberculosis alters IDH2 acetylation. Coinciding with changes in IDH2 protein, total iso-
citrate levels increased by 50% in infected J2 macrophages (Fig. 1G). These data indi-
cated a block in the TCA cycle, mirroring the decrease in IDH observed in M1 macro-
phages activated by lipopolysaccharide (24).
The complex I subunit proteins NADH:ubiquinone oxidoreductase core subunits S2
and S7 (Ndufs2 and Ndufs7), and NADH:ubiquinone oxidoreductase subunit V3
(Ndufv3) were transcriptionally downregulated in J2 macrophages at 24 h p.i. (Fig. 1H).
Primary murine BMDM also showed decreased Ndufs7 and Ndufv3 (see Fig. S1C), while
mouse RPM only showed a reduction in Ndufv3 (see Fig. S1A). Reduced complex I sub-
unit transcript expression was evident in both murine BMDM and J2 macrophages at
48 h p.i. (see Fig. S1D and E). Complex I enzymatic activity was reduced by ;50% in J2
macrophage cell lysate following infection (Fig. 1I). Despite no change in expression of
complex II, III, or IV subunits at 24 h p.i. (see Fig. S1F), complex II activity, or succinate
dehydrogenase, was decreased by .50% in J2 macrophage cell lysate (Fig. 1J). Gene
expression of the complex II subunits succinate dehydrogenase subunit A (Sdha) and
subunit D (Sdhd), as well as the complex III subunit ubiquinol-cytochrome c reductase
core protein 2 (Uqcrc2), were decreased by 48 h p.i. (see Fig. S1G). These results demon-
strated blocks in the TCA cycle and ETC at SDH, which is the only enzyme participating
in both processes. Collectively, as shown in Fig. 1K, our data revealed a shift toward
aerobic glycolysis with downregulation of the TCA and ETC in M. tuberculosis-infected
macrophages.
M. tuberculosis provokes cellular ROS accumulation and mitochondrial stress.
Electron leakage from ETC complex I is a main source of mtROS production (25).
Reduced glutathione (GSH), an important ROS scavenger, is generated from glutathi-
one disulfide (GSSG) in a reaction that requires NADPH generated by IDH2 (15, 16, 26).
Based on the downregulation of IDH2 and ETC complex I subunit genes, we predicted
that M. tuberculosis would induce oxidative stress and the mitochondrial unfolded pro-
tein response (UPRmt) in macrophages. We found that the GSH/GSSG ratio declined
more than 2-fold in J2 macrophages at 24 h p.i. (Fig. 2A), due to lower GSH (see
Fig. S2A) with GSSG levels unchanged (see Fig. S2B). Furthermore, total cellular ROS
and mtROS nearly doubled after infection (Fig. 2B and C), matching prior studies (27,
28). Remarkably, ROS increased in M. tuberculosis-infected cells despite a 4-fold
increase in Sod2 gene that detoxifies superoxide (Fig. 2D) (29). Finally, gene expression
of activating transcription factor 5 (Atf5) and heat shock protein 10 (Hsp10), mediators
of the UPRmt associated with mtROS accumulation (30–33), increased after infection
(Fig. 2E). These results suggested that M. tuberculosis infection alters expression of TCA
and ETC enzymes, leading to increased mtROS, combined with impaired ROS detoxifi-
cation that together provoke mitochondrial stress.
FIG 1 Legend (Continued)
to uninfected macrophages and show the means 6 the SD of four independent experiments. (G) Isocitrate levels in J2 macrophage
total cell lysate infected as in panel A. Error bars show the means 6 the SD of four independent experiments. (H) Gene expression of
subunits from complex I of the ETC in J2 macrophages with identical infection conditions and analysis as in panel A. Ndufs2 and
Ndufs7, NADH:ubiquinone oxidoreductase core subunit S2 and S7; Ndufv3, NADH:ubiquinone oxidoreductase subunit V3. (I and J)
Enzymatic activity of complex I (I) and complex II (J) of the ETC in J2 macrophage cell lysate infected as in panel A. The data are
expressed relative to uninfected macrophages, and error bars show the means 6 the SD of four independent experiments. (K) Model
showing the central metabolic pathways: glycolysis, TCA cycle, and OXPHOS. The arrows indicate how gene expression or metabolite
levels changed following M. tuberculosis infection. *, P , 0.05; **, P , 0.01; ***, P , 0.005.
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SIRT3 downregulation in M. tuberculosis-infected macrophages is mediated by
TLR2. To assess the relationship between metabolism and mtROS induction after M. tu-
berculosis infection, we investigated the expression of SIRT3, an enzyme that is known
to regulate mitochondrial metabolism and cellular redox homeostasis (14–16, 19, 34).
Sirtuin activity depends on NAD1 and we previously reported that macrophage NAD1
pools decrease following infection (27, 35). Speculating that M. tuberculosis modulates
sirtuin activity by a combination of cofactor depletion and transcriptional suppression,
we measured mRNA levels of the mammalian sirtuins in J2 macrophages. The expres-
sion of Sirt1, Sirt3, Sirt5, and Sirt7 were all decreased at 24 h p.i. (Fig. 3A) and this was
validated in BMDM (see Fig. S3A and B). The decrease in Sirt1 agreed with our previous
study highlighting a role of SIRT1 in TB pathogenesis (35). The decrease in mitochon-
drial sirtuins (SIRT3 and SIRT5) indicated a role for these deacetylases in the host mito-
chondrial response to M. tuberculosis. Reduced Sirt3 mRNA levels were also observed in
mouse RPM at 24 h p.i. (see Fig. S1A). To explore the kinetics of Sirt3 modulation, we
measured mRNA and protein levels at 3, 6, 18, and 24 h p.i. Sirt3 mRNA was signifi-
cantly decreased starting at 3 h and remained down through 24 h p.i. (see Fig. S3C),
while protein levels only decreased at 24 h p.i. (Fig. 3B). SIRT3 protein levels also
decreased in M. tuberculosis-infected BMDM (see Fig. S3D). To address the role of M. tu-
berculosis virulence functions in SIRT3 downregulation, we compared H37Rv with an
isogenic strain lacking the PhoPR regulator that controls both type VII secretion via
ESX1 and virulence-associated lipid production (36). This attenuated mutant downre-
gulated Sirt3, Idh2, Ndufs7, and Ndufv3 in BMDM to levels identical to that of H37Rv-
infected BMDM (Fig. 3C), suggesting that transcriptional regulation is independent of
these bacterial virulence factors.
SIRT3 is reduced in lung homogenate and alveolar macrophages treated with the
Toll-like receptor 4 (TLR4) ligand lipopolysaccharide (37), suggesting that Toll signaling
might mediate SIRT3 downregulation by M. tuberculosis. To test that hypothesis, we
challenged Myd882/2/Trif2/2 double knockout BMDM lacking signal adapters essential
for all TLR signaling (38). As predicted, infection of WT but not Myd882/2/Trif2/2 BMDM
FIG 2 M. tuberculosis induces cellular ROS accumulation and mitochondrial stress. (A) Ratio of
reduced (GSH) to oxidized (GSSG) glutathione in mouse J2 macrophage total cell lysate after M.
tuberculosis infection (MOI of 10; 24 h). The data shown are relative to uninfected macrophages and
are depicted as the means 6 the SD of four independent experiments. (B and C) Analysis of cellular
(B) and mitochondrial (mt) (C) reactive oxygen species (ROS) in J2 macrophages infected as in panel
A. The data are expressed relative to uninfected macrophages and show the means 6 the SD of
three independent experiments. (D and E) Gene expression of superoxide dismutase 2 (Sod2) (D)
and activating transcription factor 5 (Atf5) and heat shock protein 10 (Hsp10) (E) in J2
macrophages infected as in panel A. The data show the relative expression to uninfected
macrophages, expressed as the means 6 the SD of three independent experiments. *, P , 0.05;
**, P , 0.01; ***, P , 0.005.
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showed more than 50% reduction in Sirt3 by 24 h p.i. (see Fig. S3E). Next, we measured
Sirt3 levels in Tlr22/2 or Tlr42/2 J2-immortalized macrophages, finding decreased
expression in M. tuberculosis-infected WT and Tlr42/2 J2 macrophages but not in
Tlr22/2 J2 macrophages (Fig. 3D). Like Sirt3, the transcriptional regulation of Idh2,
Ndufs7, Ndufv3, and Hk2 also depended on TLR2; however, TLR4 was also important
for Hk2 regulation (Fig. 3E to H; see also Fig. S3F to H). Altogether, these results
FIG 3 M. tuberculosis-mediated downregulation of SIRT3 is TLR2-Dependent. (A) Gene expression of the mammalian sirtuins (Sirt1-7) in J2 macrophage
infected with M. tuberculosis Erdman (MOI of 10) for 24 h. Genes are expressed relative to uninfected macrophages. Plots show the means 6 the SD from
four independent experiments. (B, left) Representative immunoblot showing SIRT3 and b-actin in J2 macrophage total cell lysate after M. tuberculosis
Erdman infection for 3, 6, 18, and 24 h. (Right) Densitometry analysis of immunoblots. The data are normalized to b-actin and expressed relative to
uninfected conditions. Plots show the means 6 the SD of three independent experiments. (C) Gene expression of Sirt3, Idh2, Ndufs7, and Ndufv3
in mouse BMDM infected with H37RV or RVDphoPR (MOI of 10) for 24 h. Genes are expressed relative to uninfected macrophages and plots show the
means 6 the SD from three independent experiments. (D to H) Gene expression of sirtuin 3 (Sirt3) (D), isocitrate dehydrogenase 2 (Idh2) (E), NADH:
ubiquinone oxidoreductase core subunit S7 (Ndufs7) (F), NADH:ubiquinone oxidoreductase subunit V3 (Ndufv3) (G), and hexokinase-2 (Hk2) (H) in wild type,
Tlr22/2, and Tlr42/2 J2 macrophages with identical conditions and analysis as in panel A. *, P , 0.05; **, P , 0.01; ***, P , 0.005.
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showed that recognition of M. tuberculosis by TLR2 was required for the transcrip-
tional regulation of Sirt3 and its downstream targets.
SIRT3 regulates genes involved in central metabolism and M. tuberculosis-
induced mtROS accumulation and cell death. Since SIRT3 regulates the expression
and activity of key enzymes involved in central metabolism including IDH2 (19, 39), we
hypothesized that metabolic reprogramming by M. tuberculosis (Fig. 1) results from
SIRT3 modulation. The basal level of Idh2 mRNA in uninfected Sirt32/2 BMDM was 48%
lower than in the WT, while the cytosolic isoform Idh1 was unchanged (Fig. 4A).
Infection with M. tuberculosis produced a significant reduction in Idh2 in WT BMDM
with no reduction in Sirt32/2 BMDM (Fig. 4A). However, Idh1 was reduced in both WT
and Sirt32/2 BMDM by 24 h p.i. (Fig. 4A). Similar trends were observed for Ndufs7 and
Ndufv3 (Fig. 4B). Silencing Sirt3 in uninfected J2 macrophages (50% reduction; see
Fig. S4A) was accompanied by decreased expression of Idh2, Ndusf7, and Ndufv3 (see
Fig. S4B to D) that was not further reduced by M. tuberculosis, consistent with results
using Sirt32/2 BMDM. Together, these findings indicated that downregulation of Idh2
and the ETC complex I subunits Ndufs7 and Ndufv3 following M. tuberculosis infection
reflected SIRT3-dependent regulation.
To investigate the role of SIRT3 in regulating glycolytic enzymes, gene expression of
HK2 and PFK-P, -M, and -L was analyzed in WT and Sirt32/2 BMDM. Expression of Hk2
was 1.6-fold higher in uninfected Sirt32/2 BMDM compared to WT (Fig. 4C) and was
not further increased by M. tuberculosis, suggesting that the infection-induced increase
of Hk2 in WT macrophages resulted from SIRT3 downregulation (Fig. 4C). Unlike Hk2,
basal expression of the glycolytic enzymes Pfkp, Pfkm, and Pfkl was similar between
uninfected Sirt32/2 and WT cells, but the expression of Pfkl was increased in WT and
Sirt32/2 BMDM by 24 h p.i. (see Fig. S4E). Secreted lactate from uninfected Sirt32/2
BMDM was 20% higher than in WT controls (Fig. 4D), indicating a bias of Sirt32/2
BMDM toward glycolysis under basal conditions. M. tuberculosis significantly increased
secreted lactate in both WT and Sirt32/2 BMDM compared to uninfected WT controls
(Fig. 4D). Together, these data supported an infection-induced metabolic shift toward
glycolysis in primary and J2 macrophages due, at least in part, to reduced SIRT3
expression.
Since depletion of core ETC complex I subunits or treatment with rotenone increase
ROS production (40, 41), we considered that downregulation of complex I subunits
and reduced complex I enzymatic activity in M. tuberculosis-infected macrophages
(Fig. 1H and I) contributed to the increased ROS production that others reported (27,
42), and we confirmed (Fig. 2B and C). To demonstrate a mechanistic link between
SIRT3 and ROS, we measured cellular ROS levels in WT and Sirt32/2 BMDM. Infected WT
BMDM showed increased total cellular ROS (Fig. 4E). Basal ROS levels in Sirt32/2 BMDM
were comparable to levels in infected WT cells (Fig. 4E). Infection of Sirt32/2 BMDM
resulted in a further 1.5-fold increase of ROS compared to infected WT cells (Fig. 4E).
Uninfected Sirt32/2 BMDM demonstrated higher mtROS levels compared to WT cells
(Fig. 4F), which was not further increased by M. tuberculosis infection (Fig. 4F). Since
IDH2 is a major contributor of NADPH required for GSH production (15, 16) and since
we identified SIRT3-dependent modulation of IDH2 (Fig. 4A), we reasoned that GSH
production also depends on SIRT3. Uninfected Sirt32/2 mice showed a .75% decrease
in GSH compared to uninfected WT BMDM (Fig. 4G), while GSSG remained unchanged
(Fig. 4G), reducing the GSH/GSSG ratio by ;80% (see Fig. S4F). Infection of Sirt32/2
BMDM did not cause a further decline of GSH or the GSH/GSSG ratio compared to
uninfected Sirt32/2 or infected WT BMDM (Fig. 4G; see also Fig. S4F). Lastly, we meas-
ured mtROS in macrophages with genetic overexpression of SIRT3 and in WT BMDM
treated with the SIRT3 activator Honokiol (43). Overexpression of SIRT3 (8-fold induc-
tion; see Fig. S4G) and Honokiol treatment both prevented M. tuberculosis-induced
mtROS accumulation (Fig. 4H and I). These results demonstrated the importance of
SIRT3 in M. tuberculosis-induced mtROS accumulation.
We next assessed the role of SIRT3 in M. tuberculosis-induced UPRmt (Fig. 2E) by
measuring Atf5 in Sirt32/2 BMDM. As shown in Fig. S4H, basal Atf5 levels were similar in
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FIG 4 SIRT3 regulates genes involved in central metabolism and is important for M. tuberculosis-induced ROS
accumulation. (A to C) Gene expression of isocitrate dehydrogenase 1 and 2 (Idh1 and Idh2) (A), NADH:ubiquinone
oxidoreductase core subunit S7 (Ndufs7) and NADH:ubiquinone oxidoreductase subunit V3 (Ndufv3) (B), and hexokinase 2
(Hk2) (C) in wild type (WT) and Sirt32/2 BMDM infected with M. tuberculosis (MOI of 10) for 24 h. The data are expressed
relative to uninfected WT BMDM and show the means 6 the SD of four independent experiments. (D) Secreted lactate
levels from WT and Sirt32/2 BMDM infected with M. tuberculosis as described previously (A). Error bars show the means 6
the SD of four independent experiments. (E and F) Analysis of cellular (E) and mitochondrial (mt) (F) reactive oxygen
species (ROS) in WT and Sirt32/2 BMDM with infection conditions and analysis as in panel A of three independent
experiments. (G) Analysis of reduced (GSH) and oxidized (GSSG) glutathione in WT or Sirt32/2 BMDM total cell lysate
infected with M. tuberculosis as in panel A. Plots show the means 6 the SD of four independent experiments. (H) Analysis
of mtROS in J2 macrophages expressing single guide RNA for Sirt3 (sgSirt3) or the nontemplate control (NTC) with
identical infection conditions as described for panel A. The data are expressed relative to uninfected macrophages
expressing the NTC and show the means 6 the SD of four independent experiments. (I) Analysis of mtROS in WT BMDM
treated with 10 or 20 mM of the SIRT3 activator, honokiol (HKL), and infected as in panel A. mtROS is expressed relative to
uninfected, untreated WT BMDM, and the means 6 the SD of four independent experiments are shown. (J) Cell necrosis
of WT, Sirt32/2, and gp91phox–/– BMDM treated with the ROS scavenger MitoTEMPO (500mM) or vehicle and infected as in
panel A. The data are expressed relative to uninfected, untreated WT BMDM and show the means 6 the SD of
four independent experiments. (K) Cell necrosis of J2 macrophages expressing sgSirt3 or the NTC with identical infection
conditions as in panel A. The data are expressed relative to uninfected NTC-expressing macrophages and show the
means 6 the SD of four independent experiments. (L) Cell necrosis of WT BMDM treated with HKL (10 or 20mM) and
infected as in panel A. The data are expressed relative to uninfected, untreated WT BMDM and show the means 6 the SD
of four independent experiments. *, P , 0.05; **, P , 0.01; ***, P , 0.005.
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uninfected WT and Sirt32/2 BMDM despite higher total cellular ROS and mtROS in the
latter (Fig. 4E and F). In unstressed Sirt32/2 cells, other SIRTs presumably compensated
to prevent UPRmt. Infection of WT BMDM with M. tuberculosis raised Atf5 mRNA levels
1.6-fold, while this was increased 2.0-fold in Sirt32/2 BMDM (see Fig. S4H). These data
supported a role for SIRT3 downregulation in the accumulation of ROS and conse-
quently mitochondrial stress after M. tuberculosis infection.
We next questioned whether mtROS accumulation following SIRT3 modulation con-
tributed to M. tuberculosis-induced macrophage cell death. Cell necrosis was increased
;4-fold in M. tuberculosis-infected WT BMDM, with a further increase in Sirt32/2 BMDM
(Fig. 4J). Analysis of cell viability showed similar trends (see Fig. S4I), indicating that
Sirt32/2 cells were more susceptible to M. tuberculosis-induced cell death. Treatment
with the mitochondria-specific superoxide scavenger MitoTEMPO (500mM) prevented
M. tuberculosis-induced mtROS accumulation in WT BMDM and partially prevented
accumulation in Sirt32/2 BMDM (see Fig. S4J), while rescuing WT macrophages from
necrosis and restoring cellular viability (Fig. 4J; see also Fig. S4I). Viability and necrosis
were only partially rescued in Sirt32/2 BMDM at 24 h p.i. (Fig. 4J; see also Fig. S4I).
Furthermore, SIRT3 overexpression or activation with Honokiol partially rescued cells
from cell necrosis (Fig. 4K and L), indicating a role for SIRT3 in mtROS-induced cell
death.
Multiple sources contribute to cellular ROS, including ETC complex I, and NADPH
oxidase (44, 45). To determine whether NADPH oxidase contributed to cytotoxic ROS
accumulation, NADPH oxidase-deficient gp91phox–/– BMDM were challenged with M. tu-
berculosis and viability was assessed. Mirroring WT BMDM, M. tuberculosis induced cell
death and reduced cell viability in gp91phox–/– BMDM (Fig. 4J; see also Fig. S4I).
Treatment with MitoTEMPO to limit mtROS accumulation in gp91phox–/– BMDM (see
Fig. S4J), rescued gp91phox–/– BMDM from cell necrosis and restored cell viability similar
to WT BMDM (Fig. 4J; see also Fig. S4I). These results indicated that mtROS but not ROS
derived from NADPH oxidase played a substantial role in M. tuberculosis-induced mac-
rophage cell death and that the increased susceptibility of Sirt32/2 BMDM to cell death
was due in part to increased mtROS.
SIRT3 is required for protection againstM. tuberculosis in vivo. Since our in vitro
data identified SIRT3 as a regulator of metabolic reprogramming in M. tuberculosis-
infected macrophages in vitro, we sought to determine whether this was recapitulated
in vivo and whether it was associated with altered TB susceptibility. WT and Sirt32/2
mice were challenged with 100 CFU of M. tuberculosis Erdman and the expression of
the TCA cycle, glycolytic and ETC subunit genes in CD11b1 lung leukocytes was meas-
ured at 16 weeks p.i. The levels of Idh2 mRNA were ;40% lower in CD11b1 lung leuko-
cytes from infected Sirt32/2 mice compared to WT mice, while Idh1 showed no change
(Fig. 5A). This demonstrated regulation of Idh2 expression by SIRT3, which has not
been described before. Further matching the in vitro data (Fig. 4B), the expression of
Ndufs7 and Ndufv3 was downregulated in CD11b1 lung leukocytes from Sirt32/2 mice
(Fig. 5B). Correlating with the changes in complex I subunits and Idh2, CD11b1 lung
leukocytes from infected Sirt32/2 mice had 1.7- and 1.5-fold increases in cellular and
mtROS, respectively, compared to WT mice (Fig. 5C and D). The expression of Glut1
and Hk2 was increased 2-fold in CD11b1 lung leukocytes from infected Sirt32/2 mice
(Fig. 5E), which might also contribute to ROS accumulation (27). These results were
consistent with a role for SIRT3 as a regulator of genes involved in glycolysis, TCA, and
ETC in vivo, and they confirmed perturbations of SIRT3 mediated ROS accumulation
during M. tuberculosis infection in vitro.
Based on our in vitro data and reports on the Warburg effect in TB, we predicted
that reduced SIRT3 expression would contribute to excessive inflammation and a per-
missive environment for M. tuberculosis in the lung. WT and Sirt32/2 mice were chal-
lenged with M. tuberculosis by aerosol and monitored up to 20 weeks p.i. Sirt32/2 mice
showed increased mortality starting at 9 weeks p.i. and reaching 50% by 17 weeks
(Fig. 5F). Lung and spleen CFU were not different in WT or Sirt32/2 mice at 2 and 4
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FIG 5 SIRT3 regulates metabolic gene expression in vivo and protects host against M. tuberculosis infection. (A and B) Wild-type (WT)
and Sirt32/2 mice (n=11 per group) were infected with M. tuberculosis by aerosol and CD11b1 lung leukocytes were isolated at 16
weeks p.i. The gene expression of Idh2 and Idh1 (A) and Ndufs7 and Ndufv3 (B) was analyzed in isolated cells. The data are expressed
relative to WT and are shown as the means 6 the SD of two independent experiments. Idh, isocitrate dehydrogenase; Ndufs7, NADH:
ubiquinone oxidoreductase core subunit S7; Ndufv3, NADH:ubiquinone oxidoreductase subunit V3. (C) Analysis of cellular reactive
oxygen species (ROS) in isolated CD11b1 lung leukocytes under identical conditions as in panel A. The data are expressed relative to
the WT and shown as the means 6 the SD of two independent experiments. (D) Analysis of mitochondrial ROS (mtROS) in isolated
CD11b1 lung leukocytes from WT and Sirt32/2 mice (n=6 per group) infected as in panel A. The data are expressed relative to WT and
shown as the means 6 the SD. (E) Gene expression of glucose transporter 1 (Glut1) and hexokinase 2 (Hk2) in isolated CD11b1 lung
leukocytes under identical conditions and analysis as described for panel A. (F) Survival of M. tuberculosis-infected WT and Sirt32/2 mice
(n=11) infected as in panel A. Mice were monitored for 20weeks p.i., when all surviving mice were sacrificed. (G and H) CFU in lung (G)
and spleen (H) homogenates from WT and Sirt32/2 mice (n=11 to 13 per group) infected as in panel A. Data include CFU from 9 to
20weeks p.i., expressed as means 6 the SD of two independent experiments. (I) Representative lung histopathology by hematoxylin
and eosin staining and analysis of lesion area from WT and Sirt32/2 mice (n=9 to 10 per group) infected with M. tuberculosis as in
panel A. The size of the lesion area was analyzed using ImageJ software. Scale bar, 500mm. The data show the means 6 the SD of two
independent experiments. (J and K) CFU in lung (J) and spleen (K) homogenates from Sirt3L2/L2 and LysMcreSirtL2/L2 mice (n=11 to 12 per
group) infected as in panel A. The data include CFU from 8weeks p.i., expressed as the means 6 the SD of two independent
experiments. (L) Representative lung histopathology stained and analyzed as in panel I from Sirt3L2/L2 and LysMcreSirtL2/L2 mice (n=6 per
group) infected as in panel A. Scale bar, 500mm. The data show the means 6 the SD. *, P , 0.05; **, P , 0.01; ***, P , 0.005.
Smulan et al. ®
January/February 2021 Volume 12 Issue 1 e03140-20 mbio.asm.org 10
 on M






















weeks p.i. (see Fig. S5A and B), but the bacterial burden was significantly higher in
lungs and spleens of Sirt32/2 mice starting at 9weeks p.i. compared to WT mice
(Fig. 5G and H). The lung tissue area involved with TB immune pathology was also
greater in Sirt32/2 than in WT mice (Fig. 5I). Similar to Sirt32/2 mice, the bacterial load
was increased in the lungs, but not spleens, of M. tuberculosis-infected LysMcreSirt3L2/L2
mice compared to littermate controls at 8weeks p.i. (Fig. 5J and K). By 16weeks p.i.,
both the lungs and the spleens of LysMcreSirt3L2/L2 mice showed a greater bacterial bur-
den compared to littermate controls (see Fig. S5C and D). Infected LysMcreSirt3L2/L2 mice
also showed greater lesion area compared to littermate controls (Fig. 5L). Taken to-
gether, our data illustrated a novel role for SIRT3 in regulating macrophage mitochon-
drial and glycolytic gene expression during M. tuberculosis infection in vitro and in TB
disease in vivo.
DISCUSSION
Several studies reported that M. tuberculosis shifts mitochondrial bioenergetic me-
tabolism toward aerobic glycolysis in human and murine macrophages (2–5). We con-
firmed and extended those findings by demonstrating a role for SIRT3 as an upstream
regulator of that response. We show that SIRT3 mRNA and protein levels decreased in
M. tuberculosis-infected macrophages, along with reduced expression of mitochondrial
metabolic pathway enzymes, including the SIRT3 targets IDH2, and ETC complex I sub-
units. This resulted in isocitrate accumulation, reduced complex I and II activity, a lower
GSH/GSSG ratio, and increased mtROS. The downregulation of Idh2, Ndusf7, and
Ndufv3 was SIRT3 dependent, underscoring the importance of SIRT3 in regulating basal
mitochondrial metabolism and its dysregulation following M. tuberculosis infection.
Our data support a model where M. tuberculosis triggers TLR2, resulting in downregula-
tion of SIRT3 and its target genes leading to perturbation of mitochondrial bioener-
getics and consequently mtROS accumulation and cell death.
Kim et al. reported that a very high intranasal dose of M. tuberculosis H37Rv (3 104
CFU) provokes rapid mortality (within several days) and increased bacterial burden in
Sirt32/2 mice (20). In our study, a low-dose aerosol infection with M. tuberculosis
Erdman also increased the mortality of Sirt32/2 mice compared to WT controls. The
host-protective role of SIRT3 after infection appears to be restricted to M. tuberculosis,
rather than a generalized phenomenon, since Sirt32/2 mice do not have an altered
bacterial burden and survival when subjected to endotoxemia, Escherichia coli peritoni-
tis, Klebsiella pneumoniae pneumonia, listeriosis, or candidiasis (46). We show for the
first time the importance of macrophage-specific SIRT3 expression as the bacterial load
within lungs from LysMcreSirt3L2/L2 mice was increased, similar to Sirt32/2 mice.
Interestingly, bacterial burden within lungs of Sirt32/2 mice was higher starting at
9weeks p.i., while bacterial load was similar between Sirt32/2 and WT mice at 2 or
4weeks p.i. A recent study by Huang et al. showed that M. tuberculosis-infected alveo-
lar and interstitial macrophages have distinct metabolic states which effects bacterial
growth. Interstitial macrophages were more dependent on glycolysis than OXPHOS
and showed restrictive bacterial growth compared to alveolar macrophages (47).
Macrophages from Sirt32/2 mice may undergo a shift toward glycolysis, which could
limit bacterial growth at the earlier time points, and as infection persists, mtROS accu-
mulates leading to mitochondrial stress resulting in an environment detrimental for
the macrophage, leading to the increased bacterial load and spread. Future work will
focus on understanding the mechanisms of increased susceptibility of Sirt32/2 mice to
M. tuberculosis.
We further extended on the study by Kim et al. (20) by showing TLR2-dependent
transcriptional downregulation of Sirt3 and its target genes—Ndusf7, Ndufv3, and
Idh2—in M. tuberculosis-infected macrophages. We show that SIRT3 downregulation
increased mtROS production and lowered cellular GSH, provoking oxidative stress,
UPRmt, and macrophage cell death. Our data suggest that elevated mtROS after infec-
tion results from downregulation of SIRT3 and consequently NDUFS7 and NDUFV3.
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However, decreased SDH activity (Fig. 1J), which may increase succinate levels (48, 49),
and NAD1 hydrolysis by the tuberculosis necrotizing toxin (28, 50) could also contrib-
ute. We found no role for ROS generated by NADPH oxidase in M. tuberculosis-induced
macrophage cytolysis. Overall, these results add new understanding of complex I regu-
lation by SIRT3, demonstrating SIRT3-dependent regulation of Ndufs7 and Ndufv3 tran-
scripts in vitro and in vivo.
Mitochondrial matrix-associated IDH2 is a target of SIRT3, which increases enzy-
matic activity by deacetylation (15). We found that SIRT3 modulation by M. tuberculosis
leads to decreased IDH2 transcript and protein levels and increased levels of isocitrate.
The link between IDH2 and SIRT3 was supported by finding lower basal Idh2mRNA lev-
els in uninfected Sirt32/2 BMDM and in CD11b1 lung leukocytes from infected Sirt32/2
mice compared to WT controls. As IDH2 consumes NADP1 and generates NADPH that
maintains GSH, downregulation of IDH2 also compromises ROS detoxification (26, 51,
52). SIRT3 was previously shown to regulate cellular redox by altering IDH2 activity
(16). While we did not measure NADPH levels in M. tuberculosis-infected macrophages,
a prior study reported decreased NADPH levels in lungs of mice infected with H37Rv
(53), and we found SIRT3-dependent lowering of GSH in infected macrophages
(Fig. 4G). The combination of increased mtROS production and decreased ROS scav-
enging would potently drive oxidative stress and ROS-dependent cell death by mecha-
nisms that might include ferroptosis (42).
Along with downregulation of TCA and ETC components, we observed SIRT3-de-
pendent upregulation of Hk2 and Glut1 and increased lactate secretion following infec-
tion, indicating a shift toward glycolysis. These changes confirm and extend prior stud-
ies (3–5) and add to our earlier report of increased mitochondria-associated HK2
protein levels in M. tuberculosis-infected macrophages and a requirement of HK2 for
ROS production (27). However, a recent study reported deceleration of both OXPHOS
and glycolysis in human macrophages following M. tuberculosis infection (8). These
contrasting results may be explained by differences in cell type, as well as different
conditions of infection that bear further investigation.
We highlight SIRT3 in metabolic reprograming of M. tuberculosis-infected macro-
phages since it is the major mitochondrial sirtuin and is known to regulate mitochon-
drial and redox homeostasis (14, 16, 17, 54). However, the other mitochondrial sirtuins
(SIRT4 and SIRT5) may also be involved. We found lower SIRT5 gene expression in J2
and WT macrophages after infection, while Yang et al. (55) reported that SIRT5
uniquely binds the complex I subunit protein NDUFV3. This suggest that SIRT5 could
participate in regulating complex I activity following M. tuberculosis infection. While
SIRT4 participates in resolving lipopolysaccharide-induced inflammation by regulating
mitochondrial pyruvate dehydrogenase kinase I to rebalance mitochondrial respiration
(56), we did not detect altered SIRT4 transcript levels. Further studies will be required
to delineate the possible roles of SIRT4 and SIRT5 in M. tuberculosis-induced metabolic
reprogramming in macrophages.
Taken together, our study provides evidence that downregulation of SIRT3 is impor-
tant in the metabolic perturbation that occurs in macrophages following M. tuberculo-
sis infection and that this impacts TB pathogenesis. Whether metabolic reprogramming
benefits the host or pathogen is a complex question; both outcomes might be possible
at different phases of the host-pathogen interaction. We speculate that the perturba-
tion of mitochondrial homeostasis rapidly enhances innate host defense by increasing
aerobic glycolysis and decreasing TCA cycle and ETC activity, but at the cost of mtROS
accumulation. This may be followed by mitochondrial stress and macrophage necrosis
that subsequently lead to a pathogen permissive inflammatory environment during
chronic phase of infection.
MATERIALS ANDMETHODS
Detailed methods are presented in the supplemental material (see Text S1 in particular).
Mice. Age-matched male C57BL/6J WT (JAX 000664) and Sirt32/2 [B6.129S6(Cg)-Sirt3tm1.1Fwa/J,
JAX 027975] mice (17) were obtained from The Jackson Laboratory (Bar Harbor, ME). Lyz2 (B6.129P2-
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Lyz2tm1(cre)lfo/J, JAX 004781) and Sirt3L2/L2 mice [B6.129(Cg)-Sirt3tm1.1Auw/J, JAX 031201], obtained from The
Jackson Laboratory (Bar Harbor, Me) (57, 58), were crossed to create LysMcreSirzL2/L2 mice. Male NADPH
oxidase gp91phox–/– mice were obtained as described previously (59). Myd882/2/Trif2/2 mice were
donated by K. Fitzgerald (University of Massachusetts Medical School [UMMS]). Mice were housed in the
Animal Medicine facility at UMMS, where experiments were performed under a protocol approved by
the Institutional Animal Care and Use Committee and Institutional Biosafety Committee.
Cell isolation and culture. Murine J2-immortalized macrophages from (WT) C57BL/6J mice, Tlr22/2
and Tlr42/2 mice, developed as described previously (60), were cultured in Dulbecco modified Eagle me-
dium (DMEM) complete medium containing 10% fetal bovine serum, 0.1% 2-mercaptoethanol, and
2mM L-glutamine. For RNA silencing, 24 h before infection, J2 macrophages were transfected with
20 pmol of siRNA targeting Sirt3 (Thermo Fisher Scientific) or nontargeting control siRNA using
Lipofectamine RNAiMAX (Thermo Fisher Scientific). For BMDM, bone marrow cells from 8- to 10-week-
old age-matched male C57BL/6J, Sirt32/2, gp91phox–/–, or Myd882/2/Trif2/2 mice were differentiated for
7 days in complete DMEM supplemented with 20% L929 supernatant. For all experiments, macrophages
were split using 0.05% trypsin-EDTA, seeded at 6 105 cells/ml, and incubated at 37°C with 5% CO2 for
24 h before infection. RPM were obtained by washing the peritoneum with complete DMEM and isolat-
ing CD11b1 cells using magnetic bead separation (Miltenyi Biotec). CD11b1 cells were seeded at 1 106
cells/ml and maintained at 37°C with 5% CO2 for 24 h before infection.
Statistical analysis. GraphPad Prism 7.0 was used for statistical analysis. The results of experiments
show combined data from three to four individual experiments and are expressed as the means 6 the
standard deviations (SD). For comparison to uninfected control cells, Student t test was used to analyze
significance. One-way analysis of variance (ANOVA) was used when comparing three or more groups,
and a log-rank (Mantel-Cox) test was used for the survival study. A P value of ,0.05 was considered stat-
istically significant.
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